Show
Sort by
-
Characterization of the immune landscape of canine and feline mammary tumors as a basis for candidate biomarker, drug and toxicity studies
(2023) JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS. In Journal of Veterinary Pharmacology and Therapeutics 46(Supplement 1). p.51-52 -
Chitinase 3-like 1 stimulates macrophage-mediated lymphatic remodeling in triple-negative breast cancer
-
One cisplatin dose suffices to maintain anti-tumor immunity and enhances anti-PD-1 efficacy in an intraductal model for triple-negative breast cancer
-
- Journal Article
- A1
- open access
One cisplatin dose provides durable stimulation of anti-tumor immunity and alleviates anti-PD-1 resistance in an intraductal model for triple-negative breast cancer
-
Progression of canine mammary tumors is associated with an immunosuppressed microenvironment
-
Chitin immunomodulation stimulates anti-PD-1 therapy in an intraductal model for triple-negative breast cancer
-
Immunomodulation by cisplatin chemotherapy in an immunocompetent intraductal model for triple-negative breast cancer
-
- Journal Article
- A1
- open access
OMO-1 reduces progression and enhances cisplatin efficacy in a 4T1-based non-c-MET addicted intraductal mouse model for triple-negative breast cancer
-
Unexpected effects of a selective and potent c-MET inhibitor in an immunocompetent intraductal model for triple-negative breast cancer
-
Splenic immunomodulatory effects of cisplatin in an immunocompetent intraductal model for triple-negative breast cancer